DD159074A5 - Verfahren zur herstellung von dioxidverbindungen - Google Patents
Verfahren zur herstellung von dioxidverbindungen Download PDFInfo
- Publication number
- DD159074A5 DD159074A5 DD81230153A DD23015381A DD159074A5 DD 159074 A5 DD159074 A5 DD 159074A5 DD 81230153 A DD81230153 A DD 81230153A DD 23015381 A DD23015381 A DD 23015381A DD 159074 A5 DD159074 A5 DD 159074A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- group
- formula
- compounds
- acid
- salt
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH401780 | 1980-05-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
DD159074A5 true DD159074A5 (de) | 1983-02-16 |
Family
ID=4268255
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DD81230153A DD159074A5 (de) | 1980-05-22 | 1981-05-21 | Verfahren zur herstellung von dioxidverbindungen |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0041047A3 (fi) |
JP (1) | JPS5718685A (fi) |
KR (1) | KR830006304A (fi) |
AU (1) | AU7091181A (fi) |
DD (1) | DD159074A5 (fi) |
DK (1) | DK224281A (fi) |
FI (1) | FI811532L (fi) |
GB (1) | GB2076812A (fi) |
GR (1) | GR75639B (fi) |
IL (1) | IL62912A0 (fi) |
NO (1) | NO811740L (fi) |
PT (1) | PT73067B (fi) |
ZA (1) | ZA8103408D (fi) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4287181A (en) * | 1979-10-22 | 1981-09-01 | Pfizer Inc. | Derivatives of 6β-hydroxyalkylpenicillanic acids as β-lactamase inhibitors |
EP0083977A1 (en) * | 1982-01-11 | 1983-07-20 | Pfizer Inc. | 6-Alpha-hydroxymethylpenicillanic acid sulfone as a beta-lactamase inhibitor |
US4503040A (en) * | 1984-02-27 | 1985-03-05 | Pfizer Inc. | 6-(Aminoacyloxymethyl)penicillanic acid 1,1-dioxides as beta-lactamase inhibitors |
DE3586021D1 (de) * | 1984-07-30 | 1992-06-17 | Merck & Co Inc | Penicillin-derivate als entzuendungshemmende und degenerierungskaempfende arzneimittel. |
US4591459A (en) * | 1984-12-03 | 1986-05-27 | Pfizer Inc. | Intermediates for 6-(aminoacyloxymethyl) penicillanic acid 1,1-dioxides |
GB2206579B (en) * | 1987-07-10 | 1991-05-29 | Erba Farmitalia | 6a and 6b-(substituted methyl)-penicillanic acid derivatives |
US6156745A (en) | 1997-12-29 | 2000-12-05 | Research Corporation Technologies, Inc. | 2β-substituted-6-alkylidene penicillanic acid derivatives as β-lactamase inhibitors |
US6395726B1 (en) | 1999-01-26 | 2002-05-28 | American Cyanamid Company | 3,6-disubstituted penam sulfone derivatives |
JP2002535335A (ja) * | 1999-01-26 | 2002-10-22 | アメリカン・サイアナミド・カンパニー | 抗菌剤としての3,6−二置換ペナムスルホン誘導体 |
US6407091B1 (en) | 1999-04-15 | 2002-06-18 | Research Corporation Technologies, Inc. | β-lactamase inhibiting compounds |
ES2272795T3 (es) | 2001-07-24 | 2007-05-01 | Southern Methodist University Foundation For Research | 7-alquildieno-3-sustituidos-3-cefem-4-carboxilatos como inhibidores de beta-lactamasa. |
JP2005525399A (ja) * | 2002-04-04 | 2005-08-25 | アラムクス エルエルシー | セリンおよびメタロ−β−ラクタマーゼの阻害剤 |
PA8579701A1 (es) * | 2002-08-23 | 2005-05-24 | Pfizer Prod Inc | Profarmaco inhibidor de beta-lactamasa |
EP1636240A1 (en) * | 2003-06-05 | 2006-03-22 | Pfizer Products Inc. | Beta-lactamase inhibitor prodrug |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1102308A (en) * | 1975-09-26 | 1981-06-02 | John C. Sheehan | Carbon and oxygen analogs of cephalosporins |
US4207323A (en) * | 1975-11-21 | 1980-06-10 | Merck & Co., Inc. | 6-Substituted methyl penicillins, derivatives and analogues thereof |
US4272439A (en) * | 1978-06-02 | 1981-06-09 | Schering Corporation | 6-(Substituted-hydroxymethylene penams) |
DE2927004A1 (de) * | 1979-07-04 | 1981-05-27 | Bayer Ag, 5090 Leverkusen | Penicillansaeure-1,1-dioxide, ihre herstellung und ihre verwendung als arzneimittel als arzneimittel |
US4287181A (en) * | 1979-10-22 | 1981-09-01 | Pfizer Inc. | Derivatives of 6β-hydroxyalkylpenicillanic acids as β-lactamase inhibitors |
-
1981
- 1981-05-15 GB GB8114997A patent/GB2076812A/en not_active Withdrawn
- 1981-05-18 FI FI811532A patent/FI811532L/fi not_active Application Discontinuation
- 1981-05-18 EP EP81810188A patent/EP0041047A3/de not_active Withdrawn
- 1981-05-20 IL IL62912A patent/IL62912A0/xx unknown
- 1981-05-20 GR GR65008A patent/GR75639B/el unknown
- 1981-05-21 PT PT73067A patent/PT73067B/pt unknown
- 1981-05-21 AU AU70911/81A patent/AU7091181A/en not_active Abandoned
- 1981-05-21 DK DK224281A patent/DK224281A/da not_active Application Discontinuation
- 1981-05-21 NO NO811740A patent/NO811740L/no unknown
- 1981-05-21 DD DD81230153A patent/DD159074A5/de unknown
- 1981-05-21 ZA ZA19813408D patent/ZA8103408D/xx unknown
- 1981-05-22 JP JP7681581A patent/JPS5718685A/ja active Pending
- 1981-05-22 KR KR1019810001790A patent/KR830006304A/ko unknown
Also Published As
Publication number | Publication date |
---|---|
DK224281A (da) | 1981-11-23 |
NO811740L (no) | 1981-11-23 |
FI811532L (fi) | 1981-11-23 |
ZA8103408D (en) | 1982-06-30 |
PT73067B (en) | 1983-02-08 |
EP0041047A2 (de) | 1981-12-02 |
EP0041047A3 (de) | 1982-04-07 |
GB2076812A (en) | 1981-12-09 |
AU7091181A (en) | 1981-11-26 |
PT73067A (en) | 1981-06-01 |
GR75639B (fi) | 1984-03-02 |
KR830006304A (ko) | 1983-09-20 |
JPS5718685A (en) | 1982-01-30 |
IL62912A0 (en) | 1981-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3005164A1 (de) | Antibiotisch wirksame beta -lactamverbindungen, verfahren zu deren herstellung und sie enthaltendes arzneimittel | |
DD159074A5 (de) | Verfahren zur herstellung von dioxidverbindungen | |
DD201906A5 (de) | Verfahren zur herstellung von 7 beta-aminothiadiazolylacetylamino-3 ammoniomethyl-3-cephem-4-carbonsaeureverbindungen | |
EP0009008A2 (de) | Cephalosporinderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate | |
DD215551A5 (de) | Verfahren zur herstellung von 6-hydroxyniederalkyl-penem-verbindungen | |
DD152788A5 (de) | Verfahren zur herstellung von polyazathiaverbindungen | |
EP0246187A2 (de) | 2-Pyridyl-penem-Verbindungen | |
DE69625910T2 (de) | Penamsulfone als beta-laktamase inhibitoren | |
DE2153554A1 (de) | Thiaheterocyclische Verbindungen | |
DD211562A5 (de) | Verfahren zur herstellung von 2-heterocyclylniederalkyl-2-penem-verbindungen | |
EP0022245A2 (de) | Amino-thiadiazolyl-Verbindungen, Verfahren zu ihrer Herstellung, sie enthaltende pharmazeutische Präparate; Ausgangsverbindungen und Verfahren zu ihrer Herstellung | |
EP0000500A2 (de) | Cephalosporinderivate, Verfahren zu deren Herstellung und deren pharmazeutische Präparate | |
EP0199675A1 (de) | Heterocyclyl-penem-Verbindungen | |
CH620444A5 (en) | Process for the preparation of bicyclic unsaturated thiaaza compounds | |
DE4037841A1 (de) | Neue 3-substituierte cephalosporine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
DE2448582A1 (de) | Verfahren zur herstellung von cephalosporinen | |
DE3431980A1 (de) | Aminomethyl-verbindungen | |
EP0015240A1 (de) | Azacyclyl (thio) ureidoacetyl-Verbindungen und Verfahren zu ihrer Herstellung | |
DE2736071C2 (de) | α-Methoxy-cephalosporinderivate, Verfahren zu ihrer Herstellung sowie diese als Wirkstoffe enthaltende pharmazeutische Zubereitungen | |
DD204256A5 (de) | Verfahren zur herstellung von aminooxazolylverbindungen | |
EP0201459A1 (de) | Acylaminomethylpenemverbindungen, ihre Herstellung und sie enthaltende pharmazeutische Präparate | |
EP0037797A2 (de) | Cephalosporinverbindungen, Verfahren zu ihrer Herstellung, sie enthaltende pharmazeutische Zusammensetzungen und ihre Verwendung | |
EP0112283A1 (de) | Heterocyclylthioverbindungen, Verfahren zu ihrer Herstellung, pharmazeutische Präparate, welche diese Verbindungen enthalten, und Verwendung von letzteren | |
DE3518848A1 (de) | Aminoaethylthioverbindungen | |
DE3326194A1 (de) | Aminoimidazolyl-verbindungen, verfahren zu ihrer herstellung, pharmazeutische praeparate, welche diese vrbindungen enthalten, und verwendung von letzteren |